BioCardia, Inc. (BCDA) Earnings History
Net Loss31 years of earnings data (1995–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
BioCardia, Inc. (BCDA) Earnings Overview
As of July 8, 2026, BioCardia, Inc. (BCDA) reported trailing twelve-month net income of -$8M, reflecting +57.6% year-over-year growth. The company earned $-0.72 per diluted share over the past four quarters.
Looking at the long-term picture, BCDA's historical earnings data spans multiple years. The company achieved its highest annual net income of $10M in fiscal 2011.
BioCardia, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MCRB (-$47M net income, 721.9% margin), ANIK (-$11M net income, -9.6% margin), NVCR (-$173M net income, -20.8% margin), BCDA has comparable earnings metrics. Compare BCDA vs MCRB →
BCDA Earnings vs Peers
Earnings metrics vs comparable public companies
BCDA Historical Earnings Data (1995–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$8M | -3.5% | -$8M | $-1.23 | - | - |
| 2024 | -$8M | +31.3% | -$8M | $-2.90 | -13700.0% | -13794.8% |
| 2023 | -$12M | +2.8% | -$12M | $-8.19 | -2425.8% | -2441.1% |
| 2022 | -$12M | +5.7% | -$12M | $-10.05 | -880.7% | -880.3% |
| 2021 | -$13M | +15.9% | -$13M | $-11.19 | -1243.4% | -1244.3% |
| 2020 | -$15M | -2.0% | -$16M | $-22.20 | -10347.6% | -10709.7% |
| 2019 | -$15M | -5.2% | -$14M | $-39.15 | -2071.7% | -2001.8% |
| 2018 | -$14M | -13.6% | -$14M | $-48.80 | -2237.9% | -2256.3% |
| 2017 | -$12M | -19.4% | -$12M | $-43.50 | -2569.5% | -2589.8% |
| 2016 | -$10M | -3301.9% | -$8M | $-166.33 | -1789.9% | -1320.8% |
| 2015 | $322,000 | +37.6% | $319,000 | $27.86 | 62.3% | 61.7% |
| 2014 | $234,000 | +1131.6% | $231,000 | $20.50 | 54.8% | 54.1% |
| 2013 | $19,000 | -93.8% | $9,000 | $0.13 | 7.1% | 3.4% |
| 2012 | $305,000 | -96.8% | $-339,000 | $28.61 | 491.9% | -546.8% |
| 2011 | $10M | +184.0% | $-618,000 | $64.80 | 80516.7% | -5150.0% |
| 2010 | -$12M | -126.6% | $-583,000 | $-1079.54 | - | - |
| 2009 | -$5M | +12.4% | -$5M | $-528.72 | -271.7% | -273.0% |
| 2008 | -$6M | -1920.9% | -$6M | $-742.35 | -457.4% | -444.2% |
| 2007 | $-287,000 | -280.4% | $-312,000 | $-34.84 | -44.6% | -48.5% |
| 2006 | $-75,444 | +18.7% | $-79,802 | $-8.21 | - | - |
| 2005 | $-92,804 | +88.6% | $-92,804 | $-10.10 | - | - |
| 2004 | $-812,000 | -12.3% | $-101,000 | $-98.42 | - | - |
| 2003 | $-723,000 | -50.6% | $-780,000 | $-92.38 | -19.2% | -20.8% |
| 2002 | $-480,000 | +60.9% | $-504,000 | $-61.30 | -11.8% | -12.4% |
| 2001 | -$1M | +43.7% | -$1M | $-156.15 | -31.0% | -29.1% |
| 2000 | -$2M | -41.1% | -$2M | $-275.16 | -56.4% | -52.2% |
| 1999 | -$2M | -18.8% | -$2M | $-3293.43 | -38.7% | -48.3% |
| 1998 | -$1M | -116.7% | -$1M | $-3087.89 | -31.0% | -28.6% |
| 1997 | $-600,000 | +0.0% | -$1M | $-1459.85 | -15.8% | -28.9% |
| 1996 | $-600,000 | -542.5% | $-700,000 | $-1463.41 | -17.6% | -20.6% |
| 1995 | $135,599 | - | $206,229 | $22.00 | 4.3% | 6.6% |
Download Data
Export BCDA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BCDA — Frequently Asked Questions
Quick answers to the most common questions about buying BCDA stock.
What is BCDA earnings per share (EPS)?
BCDA trailing twelve-month (TTM) diluted EPS is $-0.72, reflecting +57.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1995 to 2025 is available in the table on this page.
What is BioCardia, Inc.'s net income?
BioCardia, Inc. (BCDA) trailing twelve-month net income is $-8M as of 2025. Earnings grew +57.6% year-over-year.
Is BCDA profitable?
BCDA is not currently profitable on a TTM basis, reporting a net loss of $-8M. Net margin is N/A. Investors should monitor for a return to profitability.
What is BCDA's earnings growth rate?
BCDA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1995 to 2025.
What are BCDA's profit margins?
BioCardia, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -950.1%.
Is BCDA growing earnings?
Yes, BCDA earnings are accelerating — EPS growth of +57.6% exceeds the 5-year CAGR of N/A. TTM net income reached $-8M. Earnings momentum is strengthening.
What was BCDA's best earnings year?
BioCardia, Inc.'s highest annual net income on record is $10M, achieved in fiscal year 2011. Earnings history on this page spans 1995 to 2025 and includes all annual and quarterly figures.
What were BCDA's earnings last quarter?
BCDA's most recent reported quarter was Q1 2026. Net income was $-2M with diluted EPS of $-0.21. For a full breakdown of all quarters, see the quarterly earnings table on this page.